CNMD Company Profile and Key Details

Q: Who are the executives of CNMD?

Mr. Terence M. BergeVice President & Corporation ControllerMr. Curt R. HartmanChairman, Chief Executive Officer & PresMr. David R. MurrayPres of ConMed ElectrosurgeryMr. Patrick J. BeyerPres of International & Global OrthopedicsMs. Heather L. CohenExecutive Vice President and Chief HR & Legal OfficerMr. John E. KennedySpecial AdvisorMs. Shanna L. Cotti-OsmanskiExecutive Vice President of Information Technology & Chief Information OfficerMr. Todd W. GarnerExecutive Vice President & Chief Financial OfficerMr. Stanley W. Peters IIIPres of Advanced Surgical & Advanced Endoscopic TechnologiesMr. Daniel S. Jonas Esq.Special Counsel & Corporation Sec.Mr. Peter K. ShagoryExecutive Vice President of Strategy & Corporation Devel.Brent LalomiaExecutive Vice President of Quality Assurance & Regulatory AffairsMr. Brent LalomiaExecutive Vice President of Quality Assurance & Regulatory AffairsMr. John FerrellExecutive Vice President of HR

NYSE : CNMD

CONMED

$38.49

0.14+0.37%

At Close 4:00 PM

68.67

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

CONMED Corporation (CNMD) stock declined over -2.70%, trading at $37.45 on NYSE, down from the previous close of $38.49. The stock opened at $37.96, fluctuating between $37.02 and $38.79 in the recent session.

Stock Snapshot

38.49

Prev. Close

1.15B

Market Cap

37.02

Day Low

24.8

P/E Ratio

1.51

EPS (TTM)

3.46

Cash Flow per Share

37.96

Open

30.83M

Number of Shares

38.79

Day High

99.11%

Free Float in %

27.12

Book Value

300.45K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 22, 2026	38.84	39.50	38.37	38.49	296.62K
Apr 21, 2026	39.72	40.64	38.25	38.35	321.69K
Apr 20, 2026	38.76	40.35	38.44	39.68	409.63K
Apr 17, 2026	38.77	39.77	38.75	39.08	280.9K
Apr 16, 2026	39.30	39.62	37.84	37.91	471.07K
Apr 14, 2026	38.77	39.96	38.77	39.73	377.08K
Apr 13, 2026	36.26	38.60	36.26	38.46	406.97K
Apr 10, 2026	37.16	37.33	36.28	36.74	248.9K
Apr 09, 2026	36.28	37.67	35.98	36.93	388.58K
Apr 08, 2026	35.88	36.96	35.88	36.59	482.88K
Apr 07, 2026	34.01	34.93	33.38	34.54	424.08K
Apr 06, 2026	34.81	35.13	33.82	34.08	384.15K
Apr 02, 2026	34.62	35.67	34.22	34.79	395.04K
Apr 01, 2026	35.59	36.27	34.95	35.53	391.89K
Mar 31, 2026	33.81	35.42	33.62	35.36	499.36K
Mar 30, 2026	34.85	35.83	33.21	33.49	516.23K
Mar 27, 2026	36.63	36.63	34.56	34.58	367.02K
Mar 25, 2026	37.06	37.25	36.11	37.08	268.93K
Mar 24, 2026	36.16	37.15	35.67	36.56	361.77K
Mar 23, 2026	36.96	37.49	35.88	36.63	396.95K

Contact Details

Largo, FL 33773-4908

United States

https://www.conmed.com 727 392 6464

About Company

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. The company markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also offers general surgery products, such as clinical insufflation, smoke evacuation, electrosurgical, and endomechanical products; and endoscopic technologies, including diagnostic and therapeutic products for use in gastroenterology procedures, and products for the treatment of diseases of the biliary structures, as well as cardiac monitoring products comprising ECG and EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

Stock Peers

PEN

5.21+1.59%

Penumbra, Inc.$332.21 SYK

2.05+0.63%

Stryker Corporation$329.35 BIO

-4.89-1.60%

Bio-Rad Laboratories, Inc.$300.78 BIO-B

22.45+8.10%

Bio-Rad Laboratories, Inc.$299.45 STE

4.1+1.87%

STERIS plc$223.55 GKOS

-0.46-0.38%

Glaukos Corporation$121.65 GMED

1.17+1.25%

Globus Medical, Inc.$95.00 ZBH

0.35+0.38%

Zimmer Biomet Holdings, Inc.$93.04 ABT

-0.98-1.06%

Abbott Laboratories$91.74 ITGR

-0.46-0.54%

Integer Holdings Corporation$85.16

Company Overview

CONMED Corporation (NYSE:CNMD) closed at $37.45 USD, losing -$1.04 (-2.70%) from the previous close of $38.49. The stock is currently mid-range between its 52-week high and low $33.21 and $61.08. With a market capitalization of about $1.15 billion, CONMED Corporation is classified as a small-cap and shows market-like volatility (beta ~0.99). Key stats such as the average daily volume over the past year has been around 491.69 thousand shares, volume is running light vs its 52-week average. Headquartered in Largo, FL, CONMED Corporation operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Patrick J. Beyer, the company employs approximately 3,900 people and listed since July 23, 1987. CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 8.46%, SMA50 10.2%, SMA200 -4.51%). The stock’s 14-day RSI is 67.86 (firm momentum), while the ATR of 1.63 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -29.29% below its high and over 29.69% above its low. Average 10-day trading volume of 366.28 thousand shares is below the 3-month average of 486.22 thousand, indicating normal recent market interest.

Valuation Metrics

CONMED Corporation trades at a P/E ratio of 24.77, slightly below the S&P 500 average, with a price-to-sales ratio of 0.84 and a price-to-book ratio of 1.13 suggesting the stock is closer to book value. The P/FCF stands at 7.69, also below market averages.

Dividend & Fair Value

CONMED Corporation last paid a dividend of 0.4 per share, this equals a trailing yield of roughly 1.06%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $91.78. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

CONMED Corporation generated EPS of $1.52 over the past year. Five-year average earnings growth is 36.14%. Wall Street analysts project EPS growth of 6.54% annually over the next five years. The latest quarter delivered EPS of $1.08. The next quarter is forecast at $0.82. Next year's EPS is expected at $25.81. Analyst sentiment is neutral. Analyst rating data shows there are 2 Strong Buy ratings, 0 Buy ratings, 5 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $68.00 to $39.00. The high target offers 76.67% upside. The low target suggests 1.33% downside. The mean target is $52.57. This offers 36.58% upside. CONMED Corporation earnings surprise history is a consistent trend of beating forecasts. The quarter that ended November 05, 2025, missed forecasts by 2.86%. The prior quarter beat by 1.77%. Over the last six quarters, Apple has recorded several small beats. These include 7.69% in July 31, 2024.

Shareholding & Insider Activity

CONMED Corporation has 30.95 million shares outstanding. The public float is 30.68 million shares, elevated short interest at 9.22% of float. This equals 2.09 million shares. The short ratio is 4.16 days. Institutional investors hold 115.55% of the float. Insiders own 0.58%. BRONSON DAVID M holds 16.46 thousand shares, Farkas Charles has 14.86 thousand shares and Jonas Daniel S has 13.46 thousand shares. Over the past six months, insider transactions show net selling. They sold 3.76 thousand shares across 2 transactions.

Financial & Profitability Overview

Over the trailing twelve months, CONMED generated $1.24B in revenue, or $39.34 per share. Gross margin was 51.82%, operating margin 10.54%, and net profit margin 5.19%. Returns are modest, with ROA at 2.80% and ROE at 7.73%.
On valuation metrics, CONMED trades at a P/E of 24.77, P/S of 0.84 and P/B of 1.13. The current ratio is 2.14 and quick ratio is 2.14. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 11.04 days. Debt-to-equity is 0.81, supported by a cash flow-to-debt ratio of 0.20.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, CONMED posted revenue of $1.24B, down slightly from $1.05B in the prior quarter. Gross profit was $643.07M (margin 51.82%). Operating income was $130.79M (margin 10.5%). Net income was$64.46M (EPS $2.10).
The company ended the quarter with $24.30M in cash and short-term investments, a total debt of $991.25M, and net debt of $966.96M. Total assets were $2.30B, with equity of $834.22M. Financials further reflected stability, with operating cash flow of $125.35M, free cash flow of $106.32M, and capital expenditures of - $19.03M.

Price Forecast & Outlook

Our AI price prediction model suggests that CONMED Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 12.44%, with price expected at $43.28 by May 06, 2026, within a range of $41.57 to $44.99 3-Month Outlook: Projected rise of 70.3%, reaching $65.55 by July 21, 2026, with a range of $62.02 to $68.39. 1-Year Outlook: Projected loss of -76.46%, with price at $9.06 by April 22, 2027, within a range of $5.68 to $12.63.

Key Takeaways

CONMED Corporation (NYSE:CNMD) shares are flat 2.51% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows CONMED Corporation trading at a premium to the broader market with a P/E of 24.77. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $96.33, suggesting 150.27% upside. Our AI forecast model points to short-term strength (12.44% over two weeks), a medium-term rise (70.3% over three months), and a longer-term loss (-76.46% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current CONMED Corporation (CNMD) stock price?

CONMED Corporation (NYSE: CNMD) stock price is $37.45 in the last trading session. During the trading session, CNMD stock reached the peak price of $38.79 while $37.02 was the lowest point it dropped to. The percentage change in CNMD stock occurred in the recent session was -2.7% while the dollar amount for the price change in CNMD stock was - $1.04.

CNMD's industry and sector of operation?

The NYSE listed CNMD is part of Medical - Devices industry that operates in the broader Healthcare sector. CONMED Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CNMD?

Mr. Terence M. Berge
Vice President & Corporation Controller
Mr. Curt R. Hartman
Chairman, Chief Executive Officer & Pres
Mr. David R. Murray
Pres of ConMed Electrosurgery
Mr. Patrick J. Beyer
Pres of International & Global Orthopedics
Ms. Heather L. Cohen
Executive Vice President and Chief HR & Legal Officer
Mr. John E. Kennedy
Special Advisor
Ms. Shanna L. Cotti-Osmanski
Executive Vice President of Information Technology & Chief Information Officer
Mr. Todd W. Garner
Executive Vice President & Chief Financial Officer
Mr. Stanley W. Peters III
Pres of Advanced Surgical & Advanced Endoscopic Technologies
Mr. Daniel S. Jonas Esq.
Special Counsel & Corporation Sec.
Mr. Peter K. Shagory
Executive Vice President of Strategy & Corporation Devel.
Brent Lalomia
Executive Vice President of Quality Assurance & Regulatory Affairs
Mr. Brent Lalomia
Executive Vice President of Quality Assurance & Regulatory Affairs
Mr. John Ferrell
Executive Vice President of HR

How CNMD did perform over past 52-week?

CNMD's closing price is 15.9% higher than its 52-week low of $33.21 where as its distance from 52-week high of $61.08 is -36.98%.

How many employees does CNMD have?

Number of CNMD employees currently stands at 3,900.

Link for CNMD official website?

Official Website of CNMD is: https://www.conmed.com

How do I contact CNMD?

CNMD could be contacted at phone 727 392 6464 and can also be accessed through its website. CNMD operates from 11311 Concept Boulevard, Largo, FL 33773-4908, United States.

How many shares of CNMD are traded daily?

CNMD stock volume for the day was 300.45K shares. The average number of CNMD shares traded daily for last 3 months was 491.69K.

What is the market cap of CNMD currently?

The market value of CNMD currently stands at $1.15B with its latest stock price at $37.45 and 30.83M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	3900
Beta	0.9
Sales or Revenue	$1.24B
5Y Sales Change%	0.328%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

CNMD Company Profile and Key Details

CONMED

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Key Takeaways

Price Forecast & Outlook